These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30607440)
41. Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway. Xu Y; Yao Y; Leng K; Ji D; Qu L; Liu Y; Cui Y Cell Physiol Biochem; 2018; 51(4):1710-1722. PubMed ID: 30504704 [TBL] [Abstract][Full Text] [Related]
42. Long non‑coding nuclear paraspeckle assembly transcript 1 acts as prognosis biomarker and increases cell growth and invasion in cervical cancer by sequestering microRNA‑101. Wang L; Zhu H Mol Med Rep; 2018 Feb; 17(2):2771-2777. PubMed ID: 29207151 [TBL] [Abstract][Full Text] [Related]
43. [Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas]. Liu N; Niu Y; Wang SL; Yu Q; Zhang RJ; Liu TJ Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1403-7. PubMed ID: 20646630 [TBL] [Abstract][Full Text] [Related]
44. Mitochondrial autoimmunity and MNRR1 in breast carcinogenesis. Aras S; Maroun MC; Song Y; Bandyopadhyay S; Stark A; Yang ZQ; Long MP; Grossman LI; Fernández-Madrid F BMC Cancer; 2019 May; 19(1):411. PubMed ID: 31046734 [TBL] [Abstract][Full Text] [Related]
45. Maspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density. Helal DS; El-Guindy DM J Egypt Natl Canc Inst; 2017 Dec; 29(4):177-183. PubMed ID: 29126758 [TBL] [Abstract][Full Text] [Related]
46. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma. Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896 [TBL] [Abstract][Full Text] [Related]
47. IQ-domain GTPase-activating protein 1 promotes the malignant phenotype of invasive ductal breast carcinoma via canonical Wnt pathway. Zhao HY; Han Y; Wang J; Yang LH; Zheng XY; Du J; Wu GP; Wang EH Tumour Biol; 2017 Jun; 39(6):1010428317705769. PubMed ID: 28618949 [TBL] [Abstract][Full Text] [Related]
48. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis]. Zhang B; Liu FF; Ma YJ; Gu F Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959 [TBL] [Abstract][Full Text] [Related]
49. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. Jiang X; Zhou Y; Sun AJ; Xue JL J Cell Physiol; 2018 Nov; 233(11):8558-8566. PubMed ID: 29323713 [TBL] [Abstract][Full Text] [Related]
50. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast. Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969 [TBL] [Abstract][Full Text] [Related]
51. Ectodomains of the LDL receptor-related proteins LRP1b and LRP4 have anchorage independent functions in vivo. Dietrich MF; van der Weyden L; Prosser HM; Bradley A; Herz J; Adams DJ PLoS One; 2010 Apr; 5(4):e9960. PubMed ID: 20383322 [TBL] [Abstract][Full Text] [Related]
52. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells. Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892 [TBL] [Abstract][Full Text] [Related]
53. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast. Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804 [TBL] [Abstract][Full Text] [Related]
54. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression. Yan P; Su Z; Zhang Z; Gao T Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599 [TBL] [Abstract][Full Text] [Related]
55. E2F-1: a proliferative marker of breast neoplasia. Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484 [TBL] [Abstract][Full Text] [Related]
56. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer. Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012 [TBL] [Abstract][Full Text] [Related]
57. Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment. Chapman JA; Miller NA; Lickley HL; Qian J; Christens-Barry WA; Fu Y; Yuan Y; Axelrod DE BMC Cancer; 2007 Sep; 7():174. PubMed ID: 17845726 [TBL] [Abstract][Full Text] [Related]
58. Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients. Giaginis C; Sampani A; Kotta-Loizou I; Giannopoulou I; Danas E; Politi E; Tsourouflis G; Kouraklis G; Patsouris E; Keramopoulos A; Nakopoulou L; Theocharis S Pathol Oncol Res; 2018 Jul; 24(3):631-640. PubMed ID: 28808873 [TBL] [Abstract][Full Text] [Related]
59. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655 [TBL] [Abstract][Full Text] [Related]
60. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics. Shatat L; Gloyeske N; Madan R; O'Neil M; Tawfik O; Fan F Hum Pathol; 2013 Dec; 44(12):2684-9. PubMed ID: 24071019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]